- Home
- ALLR vs RMCO Comparison
ALLR vs RMCO Comparison
Compare ALLR & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- RMCO
- Stock Information
- Founded
- ALLR 2004
- RMCO 2021
- Country
- ALLR United States
- RMCO United States
- Employees
- ALLR N/A
- RMCO N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- RMCO Multi-Sector Companies
- Sector
- ALLR Health Care
- RMCO Miscellaneous
- Exchange
- ALLR Nasdaq
- RMCO Nasdaq
- Market Cap
- ALLR 15.8M
- RMCO 14.9M
- IPO Year
- ALLR N/A
- RMCO N/A
- Fundamental
- Price
- ALLR $1.66
- RMCO $1.95
- Analyst Decision
- ALLR Strong Buy
- RMCO
- Analyst Count
- ALLR 1
- RMCO 0
- Target Price
- ALLR $9.00
- RMCO N/A
- AVG Volume (30 Days)
- ALLR 21.5M
- RMCO 103.1K
- Earning Date
- ALLR 08-15-2025
- RMCO 08-11-2025
- Dividend Yield
- ALLR N/A
- RMCO 0.26%
- EPS Growth
- ALLR N/A
- RMCO N/A
- EPS
- ALLR N/A
- RMCO N/A
- Revenue
- ALLR N/A
- RMCO $2,641,171.00
- Revenue This Year
- ALLR N/A
- RMCO N/A
- Revenue Next Year
- ALLR N/A
- RMCO N/A
- P/E Ratio
- ALLR N/A
- RMCO N/A
- Revenue Growth
- ALLR N/A
- RMCO 292.46
- 52 Week Low
- ALLR $0.61
- RMCO $0.82
- 52 Week High
- ALLR $3.91
- RMCO $2.34
- Technical
- Relative Strength Index (RSI)
- ALLR 59.12
- RMCO 57.14
- Support Level
- ALLR $1.78
- RMCO $1.87
- Resistance Level
- ALLR $1.92
- RMCO $2.05
- Average True Range (ATR)
- ALLR 0.25
- RMCO 0.18
- MACD
- ALLR 0.02
- RMCO -0.03
- Stochastic Oscillator
- ALLR 52.25
- RMCO 37.30
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About RMCO Royalty Management Holding Corporation
Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.